Linus Biotechnology
ApprovedLinusBio, a platform company, is developing precision environmental exposure biomarkers to support early diagnosis, patient monitoring and drug…
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $3.2M
About
LinusBio, a platform company, is developing precision environmental exposure biomarkers to support early diagnosis, patient monitoring and drug…
Diagnostics
Funding History
1Total raised:$3.2M
Seed$3.2MMar 15, 2022